p53 Protein expression and proliferative potential in non recurrent and recurrent meningiomas

Brain and Nerve

Volumn 48, Issue 8, 1996, Pages 719-725

  Miyagami, Mitsusuke ^a   Kanou, Tsuneo ^a   Nakamura, Saburou ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

malignant meningioma; meningioma; p53 protein; tumor proliferation; tumor recurrence

Indexed keywords

PROTEIN P53; TUMOR MARKER;

ARTICLE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MENINGIOMA; TUMOR RECURRENCE;

FORECASTING; HISTOCYTOCHEMISTRY; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029786295     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Chin LS, Ilinton DR: The standardized assesment of argyrophilic nucleolar organizer regions in meningeal tumors. J Neurosurg 74 : 590-596, 1991
2. Chozick BS, Pezzullo JC. Epstein MH, Finch PW : Prognostic implications of p53 overexpression in supratentorial astrocytic tumors. Neurosurgery 35 : 831-838, 1994
3. Delta A, Kenny BG, Smith C, Logan A, Hitchcock E : Correlation of proto oncogene expression and proliferation in meningiomas. Neurosurgery 3.3 : 1065-1074, 1993
4. Ellison DW, Lunec J, Gallagher PJ, Steart PV, Jaros E, Gattert KC : Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol 21 : 136-142, 1995
5. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AT : Activating mutations for transformations by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8: 531-539, 1988
6. Frankel RH. Bayona W, Koslow M, Newcomb EW : p 53 mutations in human malignant gliomas : Comparison of loss of heterozygosity with mutation frequency. Cancer Res 52 : 1427-1433, 1992
7. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM : p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res 52: 624-679. 1992
8. Hoshino T, Nagashima T, Morovic JA, Wilson CB, Davis RL : Proliferative potential of human meningiomas of brain. Cancer 58 : 1466-1472, 1986
9. Karamitopoulou E, Perentes E, Diamantis I : p53 protein expression in central nervous system tumors : An immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies. Acta Neuropathol 85: 611-616, 1993
10. Louis DN, von Deimling A, Chung RY : Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52: 31-38. 1993
11. Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K : Detection of p53 gene mutations in human brain tumors by single strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 6: 1313-1318. 1991
12. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL : Meningioma : Analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62 : 18 24, 1985
13. Miyagami M, Kasahara E, Tsubokawa T : Evaluation of the proliferation on brain tumor cells and the endothelial cells of tumor vessels using immunohistochemical study with anti-BrdU monoclonal antibody and Factor VIII related antigen. pplSl 138 (ed by Tabuchi K, Biological aspects of brain tumors. Springer Verlag, Tokyo 1991)
14. Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M, Miller DC : A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathology 3 : 229-235, 1993
15. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hosteller R, Cleary K, Bigner SH, Davidson N, Baylin S, Oevilee P : Mutations in the p53 gene occur in diverse human tumor types. Nature 342 : 705-708, 1989
16. Ohgaki H, Eibl RH, Wiestler OD, Yasargil MG, Newcomb EW, Kleihues P : p53 mutations in nonastrocytic human brain tumors. Cancer Res 51 : 6202-6205, 1991
17. Ohgaki H, Eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M, Petersen I, Roll T, Wiestler OD, Kleihues P : Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinogenesis 8: 74-80, 1993
18. Orita T, Kajiwara K, Nishizaki T, Ikeda N, Kamiryo T, Aoki H : Nucleolar organizer regions in meningioma. Neurosurgery 26: 43 46, 1990
19. Sanson M, Richard S, Delattre 0, Poliwka M, Mikol J, Philippen J, Thomas G : Allelic loss on chromosome 22 correlates with histopathological predictors of recurrence of meningiomas. Int J Cancer 50 : 391-394, 1992
20. Scarpelli M, Montironi R, Sisti S, Mariuzzi M, Brancorsini CY, Rychlicki F, Ansuini G : Quantitative evaluation of reccurrent meningiomas. Path Res Prac 185: 746-751, 1989
21. Simpson D : The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20 : 20-39, 1957
22. von Deimling A, Eibl RH, Ohgaki H : p53 mutations are associated with 17p alleic loss in grade 11 and grade III astrocytoma. Cancer Res 12 : 2987 2990, 1992